This inventor holds 10 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Bayer Corporation, Bayer Healthcare LLC, Lot 41 Acquisition Foundation, LLC. Active years: 1998-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 1,013 
4 out of 790 
1 out of 10 Years Active: 1998-2017
Title: Myung-Sam Cho: Innovator in Glycosylated Proteins
Introduction
Myung-Sam Cho is a notable inventor based in Pinole, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of glycosylated proteins with human factor VIII activity. With a total of 10 patents to his name, Cho's work has the potential to impact treatments for bleeding disorders.
Latest Patents
Among his latest patents, Cho has developed a method for treating bleeding disorders. This invention focuses on glycosylated proteins that exhibit human factor VIII activity. In a preferred embodiment, the protein is glycosylated with oligosaccharides that include an alpha-(2,6)-linked sialic acid and a bisecting GlcNAc linked to a core beta-mannose. Additionally, he has patented compositions containing factor VIII glycoforms, which also involve similar glycosylation techniques.
Career Highlights
Throughout his career, Myung-Sam Cho has worked with prominent companies such as Bayer Corporation and Bayer Healthcare LLC. His experience in these organizations has allowed him to refine his expertise in the field of biotechnology and contribute to innovative solutions for medical challenges.
Collaborations
Some of his notable coworkers include Sham-Yuen Chan and Helena Yee. Their collaborative efforts have likely enhanced the research and development of the technologies that Cho has pioneered.
Conclusion
Myung-Sam Cho's contributions to the field of glycosylated proteins and his innovative patents demonstrate his commitment to advancing medical science. His work continues to pave the way for new treatments for bleeding disorders, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile